Glutathione peroxidase, glial cells and Parkinson's disease
- PMID: 8433802
- DOI: 10.1016/0306-4522(93)90175-f
Glutathione peroxidase, glial cells and Parkinson's disease
Abstract
Hyperoxidation phenomena are suspected to be involved in dopaminergic cell death in Parkinson's disease, which affects preferentially the neuromelanin-containing dopaminergic neurons of the substantia nigra. Glutathione peroxidase is the major protective enzyme against hydrogen peroxide toxicity. The distribution of glutathione peroxidase-containing cells was investigated by immunohistochemistry in the midbrain of four control subjects and four patients with Parkinson's disease. (1) Glutathione peroxidase-like immunoreactivity was detected exclusively in glial cells. (2) In control brains, the density of glutathione peroxidase-positive cells was higher in the vicinity of the dopaminergic cell groups known to be resistant to the pathological process of Parkinson's disease. (3) In Parkinson's disease, an increased density of glutathione peroxidase-immunostained cells was observed, surrounding the surviving dopaminergic neurons. The increase in glutathione peroxidase-containing cells was correlated with the severity in dopaminergic cell loss in the respective cell groups. The data suggest that in control brains, a low density of glutathione peroxidase-positive cells surround the dopaminergic neurons the most vulnerable to Parkinson's disease, and that in parkinsonian brains, the increased number of glutathione peroxidase-positive cells may contribute to protect neurons against pathological death. Thus, the amount of glutathione peroxidase protein-containing cells may be critical for a protective effect against oxidative stress, although it cannot be excluded that the level of the enzyme activity remains the crucial factor.
Similar articles
-
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?Neurology. 1996 May;46(5):1262-9. doi: 10.1212/wnl.46.5.1262. Neurology. 1996. PMID: 8628464
-
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.Neuroscience. 1996 May;72(2):355-63. doi: 10.1016/0306-4522(95)00578-1. Neuroscience. 1996. PMID: 8737406
-
Does oxidative stress participate in nerve cell death in Parkinson's disease?Eur Neurol. 1993;33 Suppl 1:52-9. doi: 10.1159/000118538. Eur Neurol. 1993. PMID: 8375433 Review.
-
Glutathione peroxidase activity in Parkinson's disease brain.Neurosci Lett. 1985 Aug 5;58(3):343-6. doi: 10.1016/0304-3940(85)90078-3. Neurosci Lett. 1985. PMID: 4047494
-
Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?Ann Neurol. 1992;32 Suppl:S88-93. doi: 10.1002/ana.410320715. Ann Neurol. 1992. PMID: 1510386 Review.
Cited by
-
Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.Neurobiol Dis. 2015 Oct;82:243-253. doi: 10.1016/j.nbd.2015.06.010. Epub 2015 Jun 21. Neurobiol Dis. 2015. PMID: 26102022 Free PMC article.
-
Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis.Parkinsons Dis. 2012;2012:420957. doi: 10.1155/2012/420957. Epub 2012 Apr 22. Parkinsons Dis. 2012. PMID: 22577599 Free PMC article.
-
Absence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonism.Neurochem Res. 2015 May;40(5):980-90. doi: 10.1007/s11064-015-1553-x. Epub 2015 Mar 10. Neurochem Res. 2015. PMID: 25754447 Free PMC article.
-
Neurons and Glia Interplay in α-Synucleinopathies.Int J Mol Sci. 2021 May 8;22(9):4994. doi: 10.3390/ijms22094994. Int J Mol Sci. 2021. PMID: 34066733 Free PMC article. Review.
-
MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions.Mol Neurobiol. 2017 Oct;54(8):6356-6377. doi: 10.1007/s12035-016-0147-1. Epub 2016 Oct 8. Mol Neurobiol. 2017. PMID: 27722926
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical